$1.24B
$4.09 Million
0.0% of portfolio
78,240
Q3 2025
Added 0.78%
$7.49B
$10.1 Million
0.0% of portfolio
25,497
Q3 2025
Reduced 12.15%
$495M
$5.72 Million
0.0% of portfolio
1,992,870
Q3 2025
Reduced 16.0%
$2.07B
$22.5 Million
0.0% of portfolio
3,300,367
Q3 2025
Added 60.46%
-
$0
0.0% of portfolio
-
Q3 2025
New
$1.97B
$39.7 Million
0.0% of portfolio
1,210,884
Q3 2025
Added 30.41%
-
$0
0.0% of portfolio
-
Q3 2025
New
$778M
$1.16 Million
0.0% of portfolio
135,957
Q3 2025
Reduced 10.07%
$213M
$122,000
0.0% of portfolio
16,853
Q3 2025
Reduced 94.57%
$169M
$9,000
0.0% of portfolio
1,500
Q3 2025
Reduced 24.01%
$22.9M
$17,000
0.0% of portfolio
20,707
Q3 2025
Added 1,536.92%
$833M
$2.6 Million
0.0% of portfolio
1,057,968
Q3 2025
Added 3.83%
$1.58B
$116,000
0.0% of portfolio
3,205
Q1 2025
Reduced 12.14%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 21.89%
$208M
$377,000
0.0% of portfolio
32,603
Q3 2025
Reduced 94.74%
$3.55B
$2.07 Million
0.0% of portfolio
75,330
Q3 2025
Reduced 88.46%
$3.69B
$13.6 Million
0.0% of portfolio
75,165
Q3 2025
Added 56.48%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 40.13%
$23.2B
$38 Million
0.0% of portfolio
447,720
Q3 2025
Reduced 12.37%
$3.71B
$34.5 Million
0.0% of portfolio
2,106,225
Q3 2025
Added 6.61%
$3.15B
$16.8 Million
0.0% of portfolio
242,832
Q3 2025
Reduced 8.53%
$634M
$13.8 Million
0.0% of portfolio
445,911
Q3 2025
Added 6.44%
$461M
$985,000
0.0% of portfolio
242,256
Q3 2025
Added 0.18%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 307.93%
$370M
$695,000
0.0% of portfolio
119,320
Q3 2025
Reduced 5.38%
-
$0
0.0% of portfolio
-
Q3 2025
Added 1,213.96%
Inflection Pt Acquisition CO
-
$0
0.0% of portfolio
-
Q3 2025
New
$5.92B
$47.6 Million
0.0% of portfolio
1,915,516
Q3 2025
Added 17.2%
$244M
$86,000
0.0% of portfolio
14,978
Q3 2025
Reduced 79.69%
$197M
$170,000
0.0% of portfolio
16,799
Q3 2025
Added 26.81%
$97.6B
$32.4 Million
0.0% of portfolio
1,243,033
Q3 2025
Added 18.4%
$1.88B
$6.96 Million
0.0% of portfolio
126,080
Q3 2025
Added 58.37%
$1.07B
$1.92 Million
0.0% of portfolio
27,547
Q3 2025
Reduced 57.51%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 6.45%
$7.05B
$48.1 Million
0.0% of portfolio
393,923
Q3 2025
Reduced 19.23%
Inhibikase Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 24.51%
$1.18B
$9.61 Million
0.0% of portfolio
645,136
Q3 2025
Reduced 54.24%
$26M
$120,000
0.0% of portfolio
57,714
Q3 2025
Added 802.2%
$1.57B
$1.39 Million
0.0% of portfolio
19,259
Q3 2025
Added 9.68%
$1.84B
$24.8 Million
0.0% of portfolio
320,982
Q3 2025
Added 17.57%
$656M
$82,000
0.0% of portfolio
15,993
Q3 2025
Reduced 45.26%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 9.36%
$1.35B
$8.07 Million
0.0% of portfolio
150,623
Q3 2025
Added 26.2%
$0
$478,000
0.0% of portfolio
12,805
Q3 2025
New
$0
$813,000
0.0% of portfolio
11,435
Q3 2025
New
$0
$29,000
0.0% of portfolio
833
Q3 2025
Reduced 65.96%
$0
$243,000
0.0% of portfolio
5,790
Q3 2025
Added 38.92%
$0
$374,000
0.0% of portfolio
9,617
Q3 2025
Reduced 5.46%